Drugs Made In America Acq... (DMAAR)
NASDAQ: DMAAR
· Real-Time Price · USD
0.13
0.02 (18.18%)
At close: May 05, 2025, 12:06 PM
0.13
0.00%
After-hours: May 05, 2025, 04:00 PM EDT
Company Description
Drugs Made In America Acquisition Corp. operates as a blank check company.
The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Drugs Made In America Acquisition Corp. Rights
| Country | United States |
| IPO Date | n/a |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Lynn Stockwell |
Contact Details
Address: 1 East Broward Blvd Suite 700 Fort Lauderdale, Florida United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | DMAAR |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Lynn Stockwell | Chief Executive Officer & Executive Chairman |
| Glenn Charles Worman | Chief Financial Officer |